Chemokines and Bone

Annette Gilchrist, Paula H Stern*

*Corresponding author for this work

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Chemokines comprise several subfamilies of small proteins with conserved cysteine residues and common structural features. Chemokines interact with signaling receptors to elicit effects on cell migration, proliferation, and survival. Both CXC and CC subfamily chemokines promote bone formation developmentally and in response to hormonal and mechanical stimuli. Effects on homing of progenitor cells may be involved in effects on osteoblastogenesis. CXC and CC chemokines are also implicated in processes leading to osteoclastogenesis and bone resorption, with promotion of the migration of mononuclear osteoclast precursor cells being an important action. Chemokines contribute to the bone loss resulting from arthritis, both through promoting inflammation and osteoclastogenesis and attenuating cartilage repair. Both the positive effects of chemokines on bone formation and the bone loss resulting from inflammatory reactions to wear particles are factors in the success or failure of implants. In primary tumors of bone as well as cancers metastasizing to bone, chemokines facilitate interactions between tumor cells and the bone microenvironment through effects on angiogenesis, tumor growth, and invasion. Development of therapeutic agents that could target deleterious effects of chemokines, including effects on bone, has been slow, although a number of compounds for various disease indications are currently being evaluated.

Original languageEnglish (US)
Pages (from-to)61-82
Number of pages22
JournalClinical Reviews in Bone and Mineral Metabolism
Volume13
Issue number2
DOIs
StatePublished - Jun 22 2015

Fingerprint

Chemokines
Osteogenesis
Bone and Bones
CC Chemokines
Neoplasms
Cellular Microenvironment
CXC Chemokines
Osteoclasts
Bone Resorption
Arthritis
Cartilage
Cell Movement
Cysteine
Cell Survival
Stem Cells
Cell Proliferation
Inflammation
Growth
Proteins

Keywords

  • Arthritis
  • Chemokine
  • Chemokine receptor
  • Implant osseointegration
  • Metastasis
  • Osteoblastogenesis
  • Osteoclastogenesis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine
  • Endocrinology

Cite this

Gilchrist, Annette ; Stern, Paula H. / Chemokines and Bone. In: Clinical Reviews in Bone and Mineral Metabolism. 2015 ; Vol. 13, No. 2. pp. 61-82.
@article{c7b090a48bf746c1b7c92738f1da4431,
title = "Chemokines and Bone",
abstract = "Chemokines comprise several subfamilies of small proteins with conserved cysteine residues and common structural features. Chemokines interact with signaling receptors to elicit effects on cell migration, proliferation, and survival. Both CXC and CC subfamily chemokines promote bone formation developmentally and in response to hormonal and mechanical stimuli. Effects on homing of progenitor cells may be involved in effects on osteoblastogenesis. CXC and CC chemokines are also implicated in processes leading to osteoclastogenesis and bone resorption, with promotion of the migration of mononuclear osteoclast precursor cells being an important action. Chemokines contribute to the bone loss resulting from arthritis, both through promoting inflammation and osteoclastogenesis and attenuating cartilage repair. Both the positive effects of chemokines on bone formation and the bone loss resulting from inflammatory reactions to wear particles are factors in the success or failure of implants. In primary tumors of bone as well as cancers metastasizing to bone, chemokines facilitate interactions between tumor cells and the bone microenvironment through effects on angiogenesis, tumor growth, and invasion. Development of therapeutic agents that could target deleterious effects of chemokines, including effects on bone, has been slow, although a number of compounds for various disease indications are currently being evaluated.",
keywords = "Arthritis, Chemokine, Chemokine receptor, Implant osseointegration, Metastasis, Osteoblastogenesis, Osteoclastogenesis",
author = "Annette Gilchrist and Stern, {Paula H}",
year = "2015",
month = "6",
day = "22",
doi = "10.1007/s12018-015-9184-y",
language = "English (US)",
volume = "13",
pages = "61--82",
journal = "Clinical Reviews in Bone and Mineral Metabolism",
issn = "1534-8644",
publisher = "Humana Press",
number = "2",

}

Chemokines and Bone. / Gilchrist, Annette; Stern, Paula H.

In: Clinical Reviews in Bone and Mineral Metabolism, Vol. 13, No. 2, 22.06.2015, p. 61-82.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Chemokines and Bone

AU - Gilchrist, Annette

AU - Stern, Paula H

PY - 2015/6/22

Y1 - 2015/6/22

N2 - Chemokines comprise several subfamilies of small proteins with conserved cysteine residues and common structural features. Chemokines interact with signaling receptors to elicit effects on cell migration, proliferation, and survival. Both CXC and CC subfamily chemokines promote bone formation developmentally and in response to hormonal and mechanical stimuli. Effects on homing of progenitor cells may be involved in effects on osteoblastogenesis. CXC and CC chemokines are also implicated in processes leading to osteoclastogenesis and bone resorption, with promotion of the migration of mononuclear osteoclast precursor cells being an important action. Chemokines contribute to the bone loss resulting from arthritis, both through promoting inflammation and osteoclastogenesis and attenuating cartilage repair. Both the positive effects of chemokines on bone formation and the bone loss resulting from inflammatory reactions to wear particles are factors in the success or failure of implants. In primary tumors of bone as well as cancers metastasizing to bone, chemokines facilitate interactions between tumor cells and the bone microenvironment through effects on angiogenesis, tumor growth, and invasion. Development of therapeutic agents that could target deleterious effects of chemokines, including effects on bone, has been slow, although a number of compounds for various disease indications are currently being evaluated.

AB - Chemokines comprise several subfamilies of small proteins with conserved cysteine residues and common structural features. Chemokines interact with signaling receptors to elicit effects on cell migration, proliferation, and survival. Both CXC and CC subfamily chemokines promote bone formation developmentally and in response to hormonal and mechanical stimuli. Effects on homing of progenitor cells may be involved in effects on osteoblastogenesis. CXC and CC chemokines are also implicated in processes leading to osteoclastogenesis and bone resorption, with promotion of the migration of mononuclear osteoclast precursor cells being an important action. Chemokines contribute to the bone loss resulting from arthritis, both through promoting inflammation and osteoclastogenesis and attenuating cartilage repair. Both the positive effects of chemokines on bone formation and the bone loss resulting from inflammatory reactions to wear particles are factors in the success or failure of implants. In primary tumors of bone as well as cancers metastasizing to bone, chemokines facilitate interactions between tumor cells and the bone microenvironment through effects on angiogenesis, tumor growth, and invasion. Development of therapeutic agents that could target deleterious effects of chemokines, including effects on bone, has been slow, although a number of compounds for various disease indications are currently being evaluated.

KW - Arthritis

KW - Chemokine

KW - Chemokine receptor

KW - Implant osseointegration

KW - Metastasis

KW - Osteoblastogenesis

KW - Osteoclastogenesis

UR - http://www.scopus.com/inward/record.url?scp=84937641330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937641330&partnerID=8YFLogxK

U2 - 10.1007/s12018-015-9184-y

DO - 10.1007/s12018-015-9184-y

M3 - Review article

VL - 13

SP - 61

EP - 82

JO - Clinical Reviews in Bone and Mineral Metabolism

JF - Clinical Reviews in Bone and Mineral Metabolism

SN - 1534-8644

IS - 2

ER -